New treatment provided for young patient with rare neurological disorder

Texas Children’s is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved gene therapy treatment for AADC deficiency.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup